Disease · MONDO_0000481
Trials26
Trials an Open Targets clinical report links to the disease, posted results first, then the largest. A trial is shown when the release's checks confirm its link to the disease and Drugs and targets shows its link to one of the disease's drugs. 12 more are not shown, since the checks do not confirm them.
1 to 20 of 26
Download this page as JSON| Trial | Title | Phase | Participants | Results first posted | Conditions | Drugs | Linked by | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00702754 | Open Label Safety/Immunogenicity Study of MYOBLOC (Neurobloc; Botulinum Toxin Type B) in Patients With Cervical Dystonia | Phase 4 | 502 | 2009-09-23 | Cervical Dystonia | RIMABOTULINUMTOXINB | Its record names the disease | ClinicalTrials.gov |
| NCT01261611 | Study Comparing Short Term Efficacy of Dysport and Dysport NG to Placebo, and to Assess Efficacy and Safety of Dysport NG of Subjects With Cervical Dystonia | Phase 3 | 382 | 2019-09-24 | Cervical Dystonia | ABOBOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov |
| NCT00564681 | Study to Evaluate Safety, Efficacy of Botulinum Toxin Type A in Patients With Cervical Dystonia | Phase 2 | 242 | 2012-12-11 | Cervical Dystonia | ONABOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov |
| NCT00407030 | IncobotulinumtoxinA (Xeomin) Versus Placebo in the Treatment of Cervical Dystonia | Phase 3 | 233 | 2010-12-31 | Cervical Dystonia | INCOBOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov |
| NCT00165776 | Randomized, Double-Blind, Placebo-Controlled, Parallel, Group Dose-Response, Study of E2014 in Patients WIth Spasmodic Torticollis | Phase 2 | 133 | 2014-01-08 | Cervical Dystonia, Spasmodic Torticollis | RIMABOTULINUMTOXINB | Its record names the disease | ClinicalTrials.gov |
| NCT01753336 | Long Term Safety And Effectiveness Of Dysport® In Adults With Cervical Dystonia | Phase 3 | 112 | 2017-05-04 | Cervical Dystonia | ONABOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov |
| NCT04849988 | A Phase 2 Study to Evaluate the Safety and Efficacy of ABP-450 in the Treatment of Cervical Dystonia | Phase 2 | 61 | 2024-02-14 | Cervical Dystonia | PRABOTULINUMTOXIN A | Its record names the disease | ClinicalTrials.gov |
| NCT04871451 | Extension Study of ABP-19000 to Evaluate Safety and Efficacy of Repeat Treatments of ABP-450 in Cervical Dystonia | Phase 2 | 51 | 2024-08-22 | Cervical Dystonia | PRABOTULINUMTOXIN A | Its record names the disease | ClinicalTrials.gov |
| NCT00015457 | Amlodipine Plus Botulinum Toxin for Focal Dystonia | Phase 2 | 16 | 2013-04-01 | Focal Dystonia | AMLODIPINE, ONABOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov |
| NCT01753349 | Phase IV-Cervical Dystonia-INTEREST IN CD2 | 1,050 | Cervical Dystonia | ABOBOTULINUMTOXINA, BOTULINUM TOXIN TYPE A | Its record names the disease | ClinicalTrials.gov | ||
| NCT01287247 | Trial Evaluating Xeomin® (incobotulinumtoxinA) for Cervical Dystonia or Blepharospasm in the United States | 688 | Cervical Dystonia, Blepharospasm | INCOBOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov | ||
| NCT03617367 | Long-Term Safety and Efficacy of Repeat Treatments of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-OLS) | Phase 3 | 357 | Cervical Dystonia | DAXIBOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov | |
| NCT03608397 | Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) | Phase 3 | 301 | Cervical Dystonia | DAXIBOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov | |
| NCT00549341 | PurTox (Botulinum Toxin Type A) for the Treatment of Adult Onset Spasmodic Torticollis/Cervical Dystonia | Phase 1 | 70 | Spasmodic Torticollis | BOTULINUM TOXIN TYPE A | Its record names the disease | ClinicalTrials.gov | |
| NCT01655862 | A Prospective, Observational Study of Patients With Cervical Dystonia (Dystonie) Treated With OnabotulinumtoxinA | 62 | Torticollis | ONABOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov | ||
| NCT01588574 | Study for Determine the Safety and Efficacy of Clostridium Botulinum Toxin Type A in Subjects With Cervical Dystonia | Phase 2 | 60 | Cervical Dystonia | ONABOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov | |
| NCT02074293 | ASIS for Botox in Cervical Dystonia | Phase 1/2 | 60 | Cervical Dystonia Adults ,, Abnormal Head Position and Neck Pain for These 7 Muscle Groups: Splenius,Scalene,Sterno-cleido-mastoid,Levator Scapulae,Semispinalis,Trapezius,and Longissimus. | BOTULINUM TOXIN TYPE A, GADOLINIUM | Its record names the disease | ClinicalTrials.gov | |
| NCT04432285 | Long-term Outcome of DBS Versus Botulinum Toxin Treatment in Cervical Dystonia | 50 | Cervical Dystonia | ONABOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov | ||
| NCT03938363 | Analysis of Gait Before and After Botulinum Toxin Treatment in Patients With Focal Dystonia | Not applicable | 40 | Cervical Dystonia, Primary, Blepharospasm | ONABOTULINUMTOXINA | Its record names the disease | ClinicalTrials.gov | |
| NCT00418925 | Efficacy of Dronabinol for the Treatment of Cervical Dystonia | Phase 2 | 38 | Cervical Dystonia | DRONABINOL | Its record names the disease | ClinicalTrials.gov |
diseases-2026-09-18-0.1.0
Sources 6
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- NLM's MeSHNLM's terms
- Open TargetsCC0 1.0
- PubMedNLM's terms
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- NLM's MeSHNLM's
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/diseases/v1/MONDO_0000481/trials